Abstract:Abstract Background Due to the global occurrence of multi-drug-resistant malarial parasites ( Plasmodium falciparum ), the anti-malarial drug most effective against malaria is artemisinin, a natural product (sesquiterpene lactone endoperoxide) extracted from sweet wormwood ( Artemisia annua ). However, artemisinin is in short supply and unaffordable to most malaria patients. Artemisinin can be semi-synthesized from its precursor artemisinic acid, which can be synthesized from simple sugars using microorganisms genetically engineered with genes from A. annua . In order to develop an industrially competent yeast strain, detailed analyses of microbial physiology and development of gene expression strategies are required. Results Three plant genes coding for amorphadiene synthase, amorphadiene oxidase ( AMO or CYP71AV1 ), and cytochrome P450 reductase, which in concert divert carbon flux from farnesyl diphosphate to artemisinic acid, were expressed from a single plasmid. The artemisinic acid production in the engineered yeast reached 250 μg mL -1 in shake-flask cultures and 1 g L -1 in bio-reactors with the use of Leu2d selection marker and appropriate medium formulation. When plasmid stability was measured, the yeast strain synthesizing amorphadiene alone maintained the plasmid in 84% of the cells, whereas the yeast strain synthesizing artemisinic acid showed poor plasmid stability. Inactivation of AMO by a point-mutation restored the high plasmid stability, indicating that the low plasmid stability is not caused by production of the AMO protein but by artemisinic acid synthesis or accumulation. Semi-quantitative reverse-transcriptase (RT)-PCR and quantitative real time-PCR consistently showed that pleiotropic drug resistance ( PDR ) genes, belonging to the family of ATP-Binding Cassette (ABC) transporter, were massively induced in the yeast strain producing artemisinic acid, relative to the yeast strain producing the hydrocarbon amorphadiene alone. Global transcriptional analysis by yeast microarray further demonstrated that the induction of drug-resistant genes such as ABC transporters and major facilitator superfamily (MSF) genes is the primary cellular stress-response; in addition, oxidative and osmotic stress responses were observed in the engineered yeast. Conclusion The data presented here suggest that the engineered yeast producing artemisinic acid suffers oxidative and drug-associated stresses. The use of plant-derived transporters and optimizing AMO activity may improve the yield of artemisinic acid production in the engineered yeast.

Metabolic Engineering of Saccharomyces Cerevisiae for Enhanced Dihydroartemisinic Acid Production

Enhancement of Abscisic Acid Biosynthesis in Saccharomyces Cerevisiae Via Multidimensional Engineering

Heterologous Biosynthesis of Artemisinic Acid in Saccharomyces Cerevisiae

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

High-level semi-synthetic production of the potent antimalarial artemisinin

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Inducing Effect of Dihydroartemisinic Acid in the Biosynthesis of Artemisinins with Cultured Cells of Artemisia Annua by Enhancing the Expression of Genes.

Engineering Saccharomyces cerevisiae for high yield production of α-amyrin via synergistic remodeling of α-amyrin synthase and expanding the storage pool

Isolation of Dihydroartemisinic Acid from Artemisia annua L. By-Product by Combining Ultrasound-Assisted Extraction with Response Surface Methodology

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Construction of artificial yeast cell for producing amorphadiene, and optimization of fermentation

Experimental design-aided systematic pathway optimization of glucose uptake and deoxyxylulose phosphate pathway for improved amorphadiene production

Engineering Saccharomyces Cerevisiae for Hyperproduction of Β-Amyrin by Mitigating the Inhibition Effect of Squalene on Β-Amyrin Synthase.

Engineering Saccharomyces cerevisiae for high-efficient production of ursolic acid via cofactor engineering and acetyl-CoA optimization

Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

Increased artemisinin production in Artemisia annua L. by co-overexpression of six key biosynthetic enzymes

Productive Amyrin Synthases for Efficient Α-Amyrin Synthesis in Engineered Saccharomyces Cerevisiae.

Refactoring β‐amyrin synthesis in Saccharomyces cerevisiae

From Plant to Yeast-Advances in Biosynthesis of Artemisinin

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Enhanced Biosynthesis of Dihydromyricetin in Saccharomyces cerevisiae by Coexpression of Multiple Hydroxylases